GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,537,000 | -64.9% | 35,300 | -64.9% | 0.00% | -62.5% |
| Q1 2022 | $4,382,000 | -39.8% | 100,600 | -39.1% | 0.01% | -38.5% |
| Q4 2021 | $7,281,000 | +7.6% | 165,100 | -6.8% | 0.01% | +8.3% |
| Q3 2021 | $6,766,000 | -4.1% | 177,100 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $7,052,000 | +11.6% | 177,100 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $6,320,000 | -72.6% | 177,100 | -71.8% | 0.01% | -73.8% |
| Q4 2020 | $23,077,000 | -18.3% | 627,100 | -16.4% | 0.04% | -27.6% |
| Q3 2020 | $28,241,000 | -7.7% | 750,300 | 0.0% | 0.06% | -7.9% |
| Q2 2020 | $30,604,000 | +43.2% | 750,300 | +33.0% | 0.06% | +21.2% |
| Q1 2020 | $21,369,000 | -18.1% | 564,000 | +1.6% | 0.05% | +26.8% |
| Q4 2019 | $26,084,000 | +10.3% | 555,100 | +0.1% | 0.04% | +5.1% |
| Q3 2019 | $23,657,000 | +6.9% | 554,300 | +0.3% | 0.04% | +8.3% |
| Q2 2019 | $22,123,000 | +26.7% | 552,800 | +32.3% | 0.04% | +28.6% |
| Q1 2019 | $17,459,000 | +7.5% | 417,800 | -1.8% | 0.03% | -3.4% |
| Q4 2018 | $16,248,000 | -15.8% | 425,250 | -11.5% | 0.03% | 0.0% |
| Q3 2018 | $19,307,000 | +2.9% | 480,650 | +3.3% | 0.03% | 0.0% |
| Q2 2018 | $18,756,000 | +2.3% | 465,300 | -0.9% | 0.03% | 0.0% |
| Q1 2018 | $18,343,000 | +9.8% | 469,500 | -0.3% | 0.03% | +11.5% |
| Q4 2017 | $16,702,000 | +13.8% | 470,900 | +30.3% | 0.03% | +8.3% |
| Q3 2017 | $14,672,000 | -5.8% | 361,400 | 0.0% | 0.02% | -14.3% |
| Q2 2017 | $15,583,000 | -1.2% | 361,400 | -3.4% | 0.03% | -3.4% |
| Q1 2017 | $15,780,000 | +30.2% | 374,300 | +18.9% | 0.03% | +31.8% |
| Q4 2016 | $12,119,000 | +7.7% | 314,700 | +20.7% | 0.02% | 0.0% |
| Q3 2016 | $11,248,000 | +2.0% | 260,800 | +2.5% | 0.02% | -4.3% |
| Q2 2016 | $11,025,000 | +18.4% | 254,400 | +10.8% | 0.02% | +15.0% |
| Q1 2016 | $9,310,000 | -2.4% | 229,600 | -2.9% | 0.02% | -4.8% |
| Q4 2015 | $9,542,000 | +4.9% | 236,500 | 0.0% | 0.02% | +5.0% |
| Q3 2015 | $9,093,000 | +245.0% | 236,500 | +273.6% | 0.02% | +300.0% |
| Q2 2015 | $2,636,000 | -9.8% | 63,300 | 0.0% | 0.01% | -16.7% |
| Q1 2015 | $2,921,000 | +8.0% | 63,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $2,705,000 | -0.9% | 63,300 | +6.6% | 0.01% | 0.0% |
| Q3 2014 | $2,730,000 | +36.2% | 59,400 | +58.4% | 0.01% | +50.0% |
| Q2 2014 | $2,005,000 | – | 37,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |